We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,070 results
  1. Effect of rosuvastatin on sortilin and fetuin-A in type 2 diabetic patients: a randomized controlled trial

    Objective

    Rosuvastatin is a drug used for decreasing the risk of cardiovascular complications in type 2 diabetes mellitus (T2DM) patients. It is...

    Rehab H. Werida, Ola Mohamed Elattar, ... Asser Ghoneim in International Journal of Diabetes in Develo** Countries
    Article Open access 02 March 2024
  2. Evaluation of Fetuin-A level in diabetic retinopathy

    Background

    Diabetic retinopathy (DR) is a micro-vascular consequence of diabetes mellitus (DM) that manifests clinically as retinal ischemia,...

    Esraa A. M. Mostafa, Buthayna A. I. AlShaarawy, ... Asmaa M. Gamal in The Egyptian Journal of Internal Medicine
    Article Open access 13 August 2022
  3. Fetuin-A mediates the difference in adipose tissue insulin resistance between young adult pakistani and norwegian patients with type 2 diabetes

    Background

    South-Asian immigrants to Western countries have a high prevalence of type 2 diabetes mellitus (T2DM) and increased adipose tissue insulin...

    Sindre Lee-Ødegård, Thor Ueland, ... Kåre I. Birkeland in BMC Endocrine Disorders
    Article Open access 17 August 2022
  4. Fetuin-A and risk of diabetes-related vascular complications: a prospective study

    Background

    Fetuin-A is a hepatokine which has the capacity to prevent vascular calcification. Moreover, it is linked to the induction of metabolic...

    Anna Birukov, Elli Polemiti, ... Matthias B. Schulze in Cardiovascular Diabetology
    Article Open access 08 January 2022
  5. Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease

    Introduction

    Fetuin-A has been implicated in the causation of metabolic disorders such as obesity, diabetes, and hepatic steatosis. Numerous studies...

    P Ganavi Yamasandhi, Mala Dharmalingam, A. Balekuduru in Indian Journal of Gastroenterology
    Article 24 December 2021
  6. Decreases in hepatokine Fetuin-A levels are associated with hepatic hypoperfusion and predict cardiac outcomes in patients with heart failure

    Background

    Interactions of the heart and the liver remain to be fully understood in the pathophysiology of heart failure (HF). Hepatokines are...

    Yusuke Tomita, Tomofumi Misaka, ... Yasuchika Takeishi in Clinical Research in Cardiology
    Article 19 April 2022
  7. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis

    Objective

    The aim of the present study was to investigate serum fetuin-A (Fet-A) levels in patients with Takayasu arteritis (TA) and granulomatous...

    Hazan Karadeniz, Aslıhan Avanoğlu Güler, ... Şeminur Haznedaroğlu in Clinical Rheumatology
    Article 11 January 2022
  8. Fetuin-B, a potential link of liver-adipose tissue cross talk during diet-induced weight loss–weight maintenance

    Background/objectives

    Numerous hepatokines are involved in inter-organ cross talk regulating tissue-specific insulin sensitivity. Adipose tissue...

    Linna Li, Leonard Spranger, ... Knut Mai in Nutrition & Diabetes
    Article Open access 05 October 2021
  9. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells

    Aims/hypothesis

    Neonatal beta cells carry out a programme of postnatal functional maturation to achieve full glucose responsiveness. A partial loss of...

    Felicia Gerst, Elisabeth Kemter, ... Susanne Ullrich in Diabetologia
    Article Open access 25 March 2021
  10. Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss

    Heterotopic ossification (HO) is the abnormal formation of bone in extraskeletal sites. However, the mechanisms linking HO pathogenesis with bone...

    Chen Kan, Jiazhao Yang, ... Fang Ni in Bone Research
    Article Open access 27 October 2022
  11. Omega 3 fatty acids effect on the vascular calcification biomarkers fetuin A and osteoprotegerin in hemodialysis patients

    Chronic renal failure patients on dialysis are at a high risk of death due to vascular calcification. This study aimed at investigating the effect of...

    Rehab H. Werida, Sohaila Abou-Madawy, ... Maged W. Helmy in Clinical and Experimental Medicine
    Article 20 July 2021
  12. Association of fetuin-A levels and left ventricular diastolic dysfunction in patients on haemodialysis

    Objective

    To identify the relationship between serum fetuin-A levels and left ventricular diastolic dysfunction (LVDD) among maintenance haemodialysis...

    Yangang Gan, Mingming Zhao, **hong Feng in International Urology and Nephrology
    Article 06 March 2021
  13. Serum level of fetuin-A in systemic lupus erythematosus patients: association with atherosclerosis and disease activity

    Objectives

    We aimed in this study to determine the level of serum fetuin-A level in systemic lupus erythematosus patients, assess the correlation...

    Doaa Salah Atta, Ahmed Emera, ... Amina M. Elnaggar in Clinical Rheumatology
    Article 07 January 2021
  14. A case-control study to determination FBXW7 and Fetuin-A levels in patients with type 2 diabetes in Iraq

    Background

    diabetes mellitus (type 2) is a chronic disease characterized by hyperglycemia resulting either from a deficiency of insulin, or decrease...

    Suhayla K. Mohammed, Ekhlass M. Taha, Samer Abdulhasan Muhi in Journal of Diabetes & Metabolic Disorders
    Article 21 January 2021
  15. Decreased insulin resistance in diabetic patients by influencing Sirtuin1 and Fetuin-A following supplementation with ellagic acid: a randomized controlled trial

    Background

    The beneficial effects of polyphenols have been reported. This study aimed to investigate the effect of oral Ellagic acid (EA) supplement...

    Mahnaz Ghadimi, Farshad Foroughi, ... Hossein Khadem Haghighian in Diabetology & Metabolic Syndrome
    Article Open access 05 February 2021
  16. Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome

    Background

    Insulin resistance (IR) is a common characteristic of women with polycystic ovary syndrome (PCOS). It has been reported that circulating...

    Sha Liu, Wen**g Hu, ... **n Liao in BMC Endocrine Disorders
    Article Open access 19 May 2020
  17. Circulating levels of fetuin-A are associated with moderate–severe hepatic steatosis in young adults

    Purpose

    The hepatokine fetuin-A might have a role as molecular link between non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus...

    T. Filardi, F. Panimolle, ... S. Morano in Journal of Endocrinological Investigation
    Article 30 April 2020
  18. Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFα

    Objectives

    Rheumatoid arthritis (RA) is a debilitating disease, but patient management and treatment have been revolutionized since the advent of...

    Minh Vu Chuong Nguyen, Anaïs Courtier, ... Philippe Gaudin in Clinical Rheumatology
    Article 24 March 2020
Did you find what you were looking for? Share feedback.